First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Authors

Kathy Monteith, RCSI Dublin, Ireland
Lisa McSweeney, RCSI Dublin, Ireland
Colm R. Breathnach, RCSI Dublin, Ireland
Lucy Sherrin, RCSI Dublin, Ireland
Patrick Dicker, RCSI Dublin, Ireland
Elizabeth C. Tully, RCSI Dublin, Ireland
John O'Loughlin, Rotunda Hospital, Dublin
Sharon Campbell, Rotunda Hospital, Dublin
Greg Byrne, Technological University DublinFollow
Fergal Malone, RCSI Dublin, Ireland
Afif EL-Khuffash, Rotunda Hospital, Dublin
Etaoin Kent, Rotunda Hospital, Dublin
Ann Doherty, Rotunda Hospital, Dublin

Document Type

Article

Rights

Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence

Disciplines

3. MEDICAL AND HEALTH SCIENCES, 3.2 CLINICAL MEDICINE

Publication Details

Supplement to JANUARY 2018 American Journal of Obstetrics & Gynecology

Abstract

To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).

DOI

10.21427/09py-bc22

Recommended Citation

Monteith, C., McSweeney, L. & Breathnach, C.R. (2018). First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study. American Journal of Obstetrics and Gynecology, col. 218, no. 1, pp. S207-S207. doi:10.21427/09py-bc22